With booming biopharmaceutical R&D globally, pathology labs face troubles from multi-supplier coordination, inconsistent quality and high procurement costs. Chensi Biotechnology (Kunming) Co., Ltd. has launched an integrated full-process pathology solution to solve these challenges.
The package covers three core business segments. First, complete pathology equipment: microtomes, tissue printers, flotation baths, slide dryers, embedding machines, stainers and tissue processors. Second, full-spectrum lab consumables & reagents, including cell culture supplies, molecular biology kits, histology stains, immunoassay kits and general lab disposables. Third, preclinical pathology CRO testing services supported by partner Ailian Bio (Hangzhou).
“Traditional labs have to contact separate suppliers for devices, consumables and testing services, which brings heavy communication burdens,” said Chensi Bio’s management. Our one-stop system unifies quality standards and lowers overall procurement expenditure. Customized supply lists are available, and mainstream products can be shipped within 48 hours upon orders with cold-chain logistics for reagent safety.
The CRO division provides H&E staining, special staining, IHC, IF, FISH, CISH, RNAscope and AI-aided tissue quantitative analysis. Regular projects take 7–15 working days, while urgent orders can be finished within 3–5 days.
Market analysis shows integrated suppliers with equipment-consumable-service capability will gain greater competitive edges amid expanding domestic and overseas pathological testing demands.